A randomised controlled trial testing the rebound-preventing benefit of four days of prednisolone during the induction of oclacitinib therapy in dogs with atopic dermatitis
Olivry, T., Lokianskiene, V., Blanco, A., Mestre, P.D., Bergvall,K. and Beco, L. | Veterinary Dermatology | November 2022
The aim of this randomised controlled trial was to determine whether an initial four-day course of prednisolone at the start of oclacitinib therapy, would reduce pruritus rebound in dogs, one week after decreasing the frequency of oclacitinib administration…
Connect with us